Amphastar Pharmaceuticals, Inc. Proceeds from Common Stock Issued
Amphastar Pharmaceuticals, Inc. (AMPH) reported Proceeds from Common Stock Issued of $38.02 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2015-08-13
- Amphastar Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2014-12-31 was $0.00.
- Amphastar Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2014-09-30 was $0.00.
- Amphastar Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2014 was $38.02M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $0.00 derived: sum of 2 quarters · filed 2015-03-26 | $38.02M 10-K · filed 2015-03-26 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $38.02M 10-Q · filed 2014-11-13 | ||
| 2014-06-30 | $38.02M 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |